Mobile X-ray System Secures Sales Clearance In US Market on May 15
DRGEM CI
Domestic medical imaging solution company DRGEM is setting out to expand its territory in the North American medical device market by securing sales approval for its next-generation mobile X-ray system in the US market.
DRGEM announced on May 15 that its mobile X-ray system ‘RAYMO’ has finally obtained US FDA certification. FDA certification is an essential procedure that verifies the safety and efficacy of a product in accordance with global standards, and this achievement serves as an indicator that officially proves DRGEM’s manufacturing capabilities have reached the world’s highest level.
RAYMO is characterized by a lightweight and compact design applied to maximize mobility in the medical field. In particular, it is equipped with a vast array of user-centered advanced features, including a collimator source-to-image receptor distance (SID) vibration guide, a barcode scanner, radio-frequency identification (RFID), and a driving camera. These features contribute to enhancing the convenience of medical staff in complex clinical environments while simultaneously improving imaging accuracy.
Jeong-byung Park, CEO of DRGEM, evaluated, “This FDA certification is a meaningful result of having RAYMO’s unrivaled technological prowess and product competitiveness internationally recognized,” and expressed his aspiration, “We will leap forward as a key partner in the global medical imaging device market by raising brand awareness in the North American market.”
DRGEM plans to use this achievement as an opportunity to reorganize its distribution network in the North American region and continuously introduce customized solutions optimized for the local medical environment.
Choi Mun-hee
댓글
0